The DOI matches its Crossref record; 131 of the 131 references it cites were found in a registry or an index.
The pathogenesis of insulin resistance: integrating signaling pathways and substrate flux
Open accessAbstract
Insulin resistance arises when the nutrient storage pathways evolved to maximize efficient energy utilization are exposed to chronic energy surplus. Ectopic lipid accumulation in liver and skeletal muscle triggers pathways that impair insulin signaling, leading to reduced muscle glucose uptake and decreased hepatic glycogen synthesis. Muscle insulin resistance, due to ectopic lipid, precedes liver insulin resistance and diverts ingested glucose to the liver, resulting in increased hepatic de novo lipogenesis and hyperlipidemia. Subsequent macrophage infiltration into white adipose tissue (WAT) leads to increased lipolysis, which further increases hepatic triglyceride synthesis and hyperlipidemia due to increased fatty acid esterification. Macrophage-induced WAT lipolysis also stimulates hepatic gluconeogenesis, promoting fasting and postprandial hyperglycemia through increased fatty acid delivery to the liver, which results in increased hepatic acetyl-CoA content, a potent activator of pyruvate carboxylase, and increased glycerol conversion to glucose. These substrate-regulated processes are mostly independent of insulin signaling in the liver but are dependent on insulin signaling in WAT, which becomes defective with inflammation. Therapies that decrease ectopic lipid storage and diminish macrophage-induced WAT lipolysis will reverse the root causes of type 2 diabetes.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Supporting this perspective, monosaccharides have been shown to activate ChREBP and other key lipogenic transcription factors—including SREBP1c, LXR, and PPARγ—via insulin-independent mechanisms [34,70,83,86,99].”
From Hepatic Insulin Resistance and Steatosis in Metabolic Dysfunction-Associated Steatotic Liver Disease: New Insights into Mechanisms and Clinical Implications (2025) · cites this paper as [99]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“In both animal models and human patients, obesity‐induced hyperlipidaemia and lipotoxicity‐induced inflammation is thought to be one of the drivers for SO.[ 63 ]”
From Pathogenesis of sarcopenia and the relationship with fat mass: descriptive review (2022) · cites this paper as [63]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“In lipid infusion experiments, DAG content in the muscle increases, and consequently PKCθ is activated, resulting in limited phosphorylation of IRS-1 and glucose uptake through GLUT4 [9].”
From Sarcopenic obesity, insulin resistance, and their implications in cardiovascular and metabolic consequences (2020) · cites this paper as [9]
In the citing paper
“Insulin resistance is the core mechanism of sarcopenic obesity and is also associated with variable cardiometabolic diseases such as cardiovascular disease, type 2 diabetes mellitus, and non-alcoholic fatty liver disease.”
From Sarcopenic obesity, insulin resistance, and their implications in cardiovascular and metabolic consequences (2020) · cites this paper as [9]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Obesity is associated with macrophage accumulation in adipose tissue
Weisberg, S. P., McCann, D., Desai, M., Rosenbaum, M., Leibel, R. L., & Ferrante, A. W. (2003) · Journal of Clinical Investigation · doi:10.1172/jci200319246 · Cited by 10,041 · cited 1×
“Activated adipose tissue macrophages (ATMs) are recruited via chemokine signaling (96, 97) and release cytokines that promote lipolysis.”
BackgroundThe metabolic phenotype in obesity: Fat mass, body fat distribution, and adipose tissue function
Goossens, G. H. (2017) · Obesity Facts · doi:10.1159/000471488 · Cited by 8,481
Xu, H., Barnes, G. T., Yang, Q., Tan, G., Yang, D., Chou, C. J., Sole, J., Nichols, A., Ross, J. S., Tartaglia, L. A., et al. (2003) · Journal of Clinical Investigation · doi:10.1172/jci200319451 · Cited by 6,760 · cited 1×
“Activated adipose tissue macrophages (ATMs) are recruited via chemokine signaling (96, 97) and release cytokines that promote lipolysis.”
BackgroundLippa, N. C., & Sanderson, S. C. (2013) · Human Heredity · doi:10.1159/000353712 · Cited by 6,078
Adipose Tissue as an Endocrine Organ
Kershaw, E. E., & Flier, J. S. (2004) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2004-0395 · Cited by 5,522
Randle, P. J., Garland, P. B., Hales, C. N., & Newsholme, E. A. (1963) · The Lancet · doi:10.1016/s0140-6736(63)91500-9 · Cited by 5,093 · cited 2×
“Over a half century ago, Randle and colleagues concluded that muscle insulin resistance associated with obesity could be attributed to increased fatty acid oxidation that limits insulin-stimulated glucose utilization (43).”
BackgroundGenetic variation in PNPLA3 confers susceptibility to nonalcoholic fatty liver disease
Romeo, S., Kozlitina, J., Xing, C., Pertsemlidis, A., Cox, D., Pennacchio, L. A., Boerwinkle, E., Cohen, J. C., & Hobbs, H. H. (2008) · Nature Genetics · doi:10.1038/ng.257 · Cited by 3,416 · cited 1×
“A common single nucleotide polymorphism (rs738409, I48M) in the lipid droplet protein patatin-like phospholipase domaincontaining protein 3 (PNPLA3, also called adiponutrin) has been associated with increased hepatic steatosis but not insulin resistance (74).”
BackgroundKim, H. J., Park, S. Y., Choi, Y. J., Han, S. J., Lee, K. W., & Kim, D. J. (2013) · Hormone Research in Paediatrics · doi:10.1159/000348848 · Cited by 3,048
Defining the role of mTOR in cancer
Guertin, D. A., & Sabatini, D. M. (2007) · Cancer Cell · doi:10.1016/j.ccr.2007.05.008 · Cited by 2,833 · cited 1×
“Insulin activates the insulin receptor tyrosine kinase (IRTK), with subsequent activation of kinases including 3-phosphoinositide-dependent kinase-1 (PDK1) and mTORC2 (6), which converge on Akt phosphorylation (6–8).”
BackgroundAlessi, D. R., James, S. R., Downes, C. P., Holmes, A. B., Gaffney, P. R. J., Reese, C. B., & Cohen, P. (1997) · Current Biology · doi:10.1016/s0960-9822(06)00122-9 · Cited by 2,826
Research works printed but not linked: 6
- 10.1210/jcem.87.8.8761 · doi:10.1210/jcem.87.8.8761 · Paper page
- Kersten, 2014, Physiological regulation of lipoprotein lipase, Biochim Biophys Acta, 1841, 919, 10.1016/j.bbalip.2014.03.013 · DOI · Paper page
- 10.1172/JCI10294 · DOI · Paper page
- 10.1172/JCI15001 · doi:10.1172/jci15001 · Paper page
- 10.1172/JCI19246 · doi:10.1172/jci19246 · Paper page
- 10.1172/JCI19451 · doi:10.1172/jci19451 · Paper page
Cited by
Mechanisms of NAFLD development and therapeutic strategies
Friedman, S. L., Neuschwander-Tetri, B. A., Rinella, M., & Sanyal, A. J. (2018) · Nature Medicine · doi:10.1038/s41591-018-0104-9 · Cited by 4,354
Mechanisms of Insulin Action and Insulin Resistance
Petersen, M. C., & Shulman, G. I. (2018) · Physiological Reviews · doi:10.1152/physrev.00063.2017 · Cited by 3,028
Self-citationAssociation between insulin resistance and the development of cardiovascular disease
Ormazabal, V., Nair, S., Elfeky, O., Aguayo, C., Salomon, C., & Zuñiga, F. A. (2018) · Cardiovascular Diabetology · doi:10.1186/s12933-018-0762-4 · Cited by 2,280
Inflammation in obesity, diabetes, and related disorders
Rohm, T. V., Meier, D. T., Olefsky, J. M., & Donath, M. Y. (2022) · Immunity · doi:10.1016/j.immuni.2021.12.013 · Cited by 2,066
Diabetic Cardiomyopathy: An Update of Mechanisms Contributing to This Clinical Entity
Jia, G., Hill, M. A., & Sowers, J. R. (2018) · Circulation Research · doi:10.1161/circresaha.117.311586 · Cited by 1,807
“obese humans can be correlated to elevated diacylglycerol content and PKC ε (protein kinase Cε) activation.(60) Diacylglycerol increases lipid-associated endoplasmic reticulum stress.”
BackgroundSREBP-regulated lipid metabolism: convergent physiology - divergent pathophysiology
Shimano, H., & Sato, R. (2017) · Nature Reviews Endocrinology · doi:10.1038/nrendo.2017.91 · Cited by 1,174
Insulin action and resistance in obesity and type 2 diabetes
Czech, M. P. (2017) · Nature Medicine · doi:10.1038/nm.4350 · Cited by 1,258
Regulation of hepatic glucose metabolism in health and disease
Petersen, M. C., Vatner, D. F., & Shulman, G. I. (2017) · Nature Reviews Endocrinology · doi:10.1038/nrendo.2017.80 · Cited by 1,133
Self-citationTriglyceride-glucose index as a marker in cardiovascular diseases: landscape and limitations
Tao, L.-C., Xu, J.-N., Wang, T.-T., Hua, F., & Li, J.-J. (2022) · Cardiovascular Diabetology · doi:10.1186/s12933-022-01511-x · Cited by 1,042
“Studies have suggested that increased TG levels can induce elevated free fatty acid (FFA) levels and promote the increased flux of FFAs from adipose tissue to non-adipose tissue, which may accompany IR [70].”
BackgroundTriglyceride Metabolism in the Liver
Alves‐Bezerra, M., & Cohen, D. E. (2017) · Comprehensive Physiology · doi:10.1002/cphy.c170012 · Cited by 1,016
“Under fasting conditions when plasma insulin concentrations are low, a lipolytic program is initiated in white adipose tissue, which increases the plasma FA pool that is available for uptake by the liver (12,214) (Fig.”
Insulin resistance: review of the underlying molecular mechanisms
Yaribeygi, H., Farrokhi, F. R., Butler, A. E., & Sahebkar, A. (2019) · Journal of Cellular Physiology · doi:10.1002/jcp.27603 · Cited by 929
“IR is a complex pathological state of inappropriate cellular response to insulin hormone in insulin‐dependent cells such as adipocytes and cardiomyocytes (Samuel & Shulman, 2016).”
BackgroundInfluentialKalinkovich, A., & Livshits, G. (2017) · Ageing Research Reviews · doi:10.1016/j.arr.2016.09.008 · Cited by 882
Nonalcoholic fatty liver disease as a nexus of metabolic and hepatic diseases
Samuel, V. T., & Shulman, G. I. (2018) · Cell Metabolism · doi:10.1016/j.cmet.2017.08.002 · Cited by 745
“A complete accounting for all the pathways that regulate hepatic lipid and glucose metabolism is beyond the scope of this review and was recently reviewed in greater detail elsewhere (Samuel and Shulman, 2016).”
Self-citationAL-Ishaq, R. K., Abotaleb, M., Kubatka, P., Kajo, K., & Büsselberg, D. (2019) · Biomolecules · doi:10.3390/biom9090430 · Cited by 741
“In order to combat insulin resistance, the body increases the production of insulin to maintain euglycemia leading to an increase in the size of islet cells and pancreatic β-cells [23].”
BackgroundHypertension, diabetes, atherosclerosis and NASH: Cause or consequence?
Lonardo, A., Nascimbeni, F., Mantovani, A., & Targher, G. (2018) · Journal of Hepatology · doi:10.1016/j.jhep.2017.09.021 · Cited by 736
“The key role of hepatic ceramides in the development of IR has been reviewed elsewhere.(170) Experimental”
BackgroundInfluentialCircadian clocks and insulin resistance
Stenvers, D. J., Scheer, F. A. J. L., Schrauwen, P., la Fleur, S. E., & Kalsbeek, A. (2019) · Nature Reviews Endocrinology · doi:10.1038/s41574-018-0122-1 · Cited by 733
Molecular Mechanisms Linking Oxidative Stress and Diabetes Mellitus
Yaribeygi, H., Sathyapalan, T., Atkin, S. L., & Sahebkar, A. (2020) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2020/8609213 · Cited by 685
“Normal insulin signal transduction (IST) has complex sequential steps involving different enzymes and mediators, which results in facilitated glucose entry into the adipocytes, muscles, and myocardial cells via GLUT-4 (glucose transporter4) transporters [8, 34].”
BackgroundInfluentialWitchel, S. F., Oberfield, S. E., & Peña, A. S. (2019) · Journal of the Endocrine Society · doi:10.1210/js.2019-00078 · Cited by 653
“IR decreases suppression of adipocyte lipolysis, resulting in increased serum free fatty acids and triglycerides, ultimately leading to increased hepatic de novo lipogenesis and hyperlipidemia [83].”
BackgroundPathogenesis of sarcopenia and the relationship with fat mass: descriptive review
Li, C., Yu, K., Shyh‐Chang, N., Jiang, Z., Liu, T., Ma, S., Luo, L., Guang, L., Liang, K., Ma, W., et al. (2022) · Journal of Cachexia, Sarcopenia and Muscle · doi:10.1002/jcsm.12901 · Cited by 626
“This means many ‘normal’ subjects in current studies could actually be SO subjects that were not suspected nor tested for (pre-)sarcopenia, and we might be grossly underestimating both the prevalence and the impact of SO.”
BackgroundInfluentialVekic, J., Zeljkovic, A., Stefanovic, A., Jelic-Ivanovic, Z., & Spasojevic-Kalimanovska, V. (2019) · Metabolism · doi:10.1016/j.metabol.2018.11.005 · Cited by 612
EPIC-InterAct Consortium, Lotta, L. A., Cambridge FPLD1 Consortium, Gulati, P., Day, F. R., Payne, F., Ongen, H., van de Bunt, M., Gaulton, K. J., Eicher, J. D., et al. (2017) · Nature Genetics · doi:10.1038/ng.3714 · Cited by 585
“…as an impaired ability of insulin to maintain normal glucose metabolism and initially manifested as higher levels of circulating insulin, is positively associated with adi posity and is a key mediator of the link between obesity and its adverse impact on metabolic and cardiovascular disease 1–8 .”
Insulin regulation of gluconeogenesis
Hatting, M., Tavares, C. D. J., Sharabi, K., Rines, A. K., & Puigserver, P. (2018) · Annals of the New York Academy of Sciences · doi:10.1111/nyas.13435 · Cited by 587
Cardiovascular consequences of metabolic syndrome
Tune, J. D., Goodwill, A. G., Sassoon, D. J., & Mather, K. J. (2017) · Translational Research · doi:10.1016/j.trsl.2017.01.001 · Cited by 568
Palmitic and Oleic Acid: The Yin and Yang of Fatty Acids in Type 2 Diabetes Mellitus
Palomer, X., Pizarro-Delgado, J., Barroso, E., & Vázquez-Carrera, M. (2018) · Trends in Endocrinology & Metabolism · doi:10.1016/j.tem.2017.11.009 · Cited by 548
Cytosolic lipolysis and lipophagy: two sides of the same coin
Zechner, R., Madeo, F., & Kratky, D. (2017) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm.2017.76 · Cited by 550
Non-alcoholic fatty liver disease: the interplay between metabolism, microbes and immunity
Tilg, H., Adolph, T. E., Dudek, M., & Knolle, P. (2021) · Nature Metabolism · doi:10.1038/s42255-021-00501-9 · Cited by 507
The cell biology of systemic insulin function
Tokarz, V. L., MacDonald, P. E., & Klip, A. (2018) · Journal of Cell Biology · doi:10.1083/jcb.201802095 · Cited by 471
“…often causally related to insulin resistance, hypertension, and type 2 diabetes (Taniguchi et al., 2006; Hoehn et al., 2008; Odegaard and Chawla, 2013; Boucher et al., 2014; DeFronzo et al., 2015; Samuel and Shulman, 2016; Haeusler et al., 2018; also see other important highlights in the text box).”
BackgroundNeeland, I. J., Lim, S., Tchernof, A., Gastaldelli, A., Rangaswami, J., Ndumele, C. E., Powell-Wiley, T. M., & Després, J.-P. (2024) · Nature Reviews Disease Primers · doi:10.1038/s41572-024-00563-5 · Cited by 463
An Integrated View of Immunometabolism
Lee, Y. S., Wollam, J., & Olefsky, J. M. (2018) · Cell · doi:10.1016/j.cell.2017.12.025 · Cited by 436
“Other factors that can influence systemic insulin resistance, such as lipotoxicity, ectopic lipid distribution, and non-inflammation-induced defects in insulin action, are the subject of a number of other excellent reviews (Czech, 2017; Newgard, 2017; Samuel and Shulman, 2016), and the reader is referred to these publ…”
BackgroundInfluentialChaudhry, A., Shi, R., & Luciani, D. S. (2020) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00457.2019 · Cited by 423
Critical review on the presence of phthalates in food and evidence of their biological impact
Giuliani, A., Zuccarini, M., Cichelli, A., Khan, H., & Reale, M. (2020) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph17165655 · Cited by 420
Pathogenesis of Nonalcoholic Steatohepatitis: An Overview
Parthasarathy, G., Revelo, X., & Malhi, H. (2020) · Hepatology Communications · doi:10.1002/hep4.1479 · Cited by 414
“Insulin resistance (IR) and NAFLD are crucially linked(2,11); IR leads to reduced glucose uptake in adipocytes and muscles, and hepatocytes can secrete dipeptidyl peptidase 4, which promotes adipose tissue inflammation and IR.”
BackgroundZhao, H., Zhang, J., Cheng, X., Nie, X., & He, B. (2023) · Journal of Ovarian Research · doi:10.1186/s13048-022-01091-0 · Cited by 408
“Direct effects activate de novo lipogenesis, convert excess carbohydrate substrates to triglycerides, and promote liver triglyceride delivery to adipose tissue [82].”
BackgroundInfluentialHong, S.-H., & Choi, K. M. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21020494 · Cited by 390
“In genetic mouse models of muscle-specific IR, by deleting the IRTK [142] or GLUT4 [143] genes, hepatic steatosis and adiposity were increased [142].”
BackgroundInfluentialTargeting hepatic glucose metabolism in the treatment of type 2 diabetes
Rines, A. K., Sharabi, K., Tavares, C. D. J., & Puigserver, P. (2016) · Nature Reviews Drug Discovery · doi:10.1038/nrd.2016.151 · Cited by 375
Sergi, D., Naumovski, N., Heilbronn, L. K., Abeywardena, M., O’Callaghan, N., Lionetti, L., & Luscombe-Marsh, N. (2019) · Frontiers in Physiology · doi:10.3389/fphys.2019.00532 · Cited by 347
Nonalcoholic fatty liver disease (NAFLD) from pathogenesis to treatment concepts in humans
Pafili, K., & Roden, M. (2021) · Molecular Metabolism · doi:10.1016/j.molmet.2020.101122 · Cited by 330
“Obesity-related insulin resistance is further accompanied by macrophage infiltration and local increase in inflammatory cytokines in the adipose tissue [93].”
BackgroundCarbone, S., Del Buono, M. G., Ozemek, C., & Lavie, C. J. (2019) · Progress in Cardiovascular Diseases · doi:10.1016/j.pcad.2019.08.004 · Cited by 327
Sarcopenia during COVID-19 lockdown restrictions: long-term health effects of short-term muscle loss
Kirwan, R., McCullough, D., Butler, T., Perez de Heredia, F., Davies, I. G., & Stewart, C. (2020) · GeroScience · doi:10.1007/s11357-020-00272-3 · Cited by 324
Akkermansia muciniphila improves metabolic profiles by reducing inflammation in chow diet-fed mice
Zhao, S., Liu, W., Wang, J., Shi, J., Sun, Y., Wang, W., Ning, G., Liu, R., & Hong, J. (2017) · Journal of Molecular Endocrinology · doi:10.1530/jme-16-0054 · Cited by 298
“…http://jme.endocrinology-journals.org © 2017 Society for Endocrinology Printed in Great Britain Published by Bioscientifica Ltd. s zhao, w liu, j wang and others Akkermansia muciniphila improves metabolic profile that impair insulin signaling thereby insulin resistance (Samuel & Shulman 2016).”
Macrophages in obesity and non-alcoholic fatty liver disease: crosstalk with metabolism
Lefere, S., & Tacke, F. (2019) · JHEP Reports · doi:10.1016/j.jhepr.2019.02.004 · Cited by 278
“Beside their promotion of insulin resistance, proinflammatory macrophages also directly stimulate lipolysis, which is key in increasing lipid flux to the skeletal muscle and liver.(77) Mechanistically, proinflammatory cytokines secreted by ATMs downregulate lipid droplet-associated peptides, thereby decreasing lipid d…”
BackgroundFresh insights into glucocorticoid-induced diabetes mellitus and new therapeutic directions
Li, J.-X., & Cummins, C. L. (2022) · Nature Reviews Endocrinology · doi:10.1038/s41574-022-00683-6 · Cited by 257
Sarcopenic obesity: time to meet the challenge
Barazzoni, R., Bischoff, S. C., Boirie, Y., Busetto, L., Cederholm, T., Dicker, D., Toplak, H., Van Gossum, A., Yumuk, V., & Vettor, R. (2018) · Clinical Nutrition · doi:10.1016/j.clnu.2018.04.018 · Cited by 260
Rieusset, J. (2018) · Cell Death & Disease · doi:10.1038/s41419-018-0416-1 · Cited by 248
Adipocyte lipolysis: from molecular mechanisms of regulation to disease and therapeutics
Yang, A., & Mottillo, E. P. (2020) · Biochemical Journal · doi:10.1042/bcj20190468 · Cited by 246
Sarcopenic obesity: time to meet the challenge
Barazzoni, R., Bischoff, S., Boirie, Y., Busetto, L., Cederholm, T., Dicker, D., Toplak, H., Van Gossum, A., Yumuk, V., & Vettor, R. (2018) · Obesity Facts · doi:10.1159/000490361 · Cited by 244
The circadian clock and liver function in health and disease
Mukherji, A., Bailey, S. M., Staels, B., & Baumert, T. F. (2019) · Journal of Hepatology · doi:10.1016/j.jhep.2019.03.020 · Cited by 246
“Importantly, insulin resistance also plays a critical, if not indispensable role in NAFLD ((36,38,45)).”
BackgroundMechanisms of muscle insulin resistance and the cross‐talk with liver and adipose tissue
Silva Rosa, S. C., Nayak, N., Caymo, A. M., & Gordon, J. W. (2020) · Physiological Reports · doi:10.14814/phy2.14607 · Cited by 240
“…by the accumulation of lipid intermediates such as diacylglycerols (DAGs), ceramides, and triglycerides that facilitate the development of insulin resistssance in muscle, liver, and adipose tissue (Erion & Shulman, 2010; Gordon et al., 2015; Petersen & Shulman, 2018; Samuel & Shulman, 2016).”
BackgroundCai, W., Xu, J., Wu, X., Chen, Z., Zeng, L., Song, X., Zeng, Y., & Yu, F. (2023) · Cardiovascular Diabetology · doi:10.1186/s12933-023-01864-x · Cited by 220
“Secondly, the TyG index may reflect the metabolism of glycosylation products, and platelet reactivity, which can result in endothelial cell-dependent vasodilation [48].”
BackgroundInsulin and Insulin Receptors in Adipose Tissue Development
Cignarelli, A., Genchi, V. A., Perrini, S., Natalicchio, A., Laviola, L., & Giorgino, F. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20030759 · Cited by 219
“, reduced insulin signaling, reduced glucose transport, reduced fatty acid transport) result in a failure of lipolysis suppression, impaired glucose uptake, and a consequent reduction of glycerol-3-phosphate production (required for fatty acid esterification [94]), as well as reduced fatty acid availability intracellu…”
BackgroundLinks between metabolic syndrome and metabolic dysfunction-associated fatty liver disease
Lim, S., Kim, J.-W., & Targher, G. (2021) · Trends in Endocrinology & Metabolism · doi:10.1016/j.tem.2021.04.008 · Cited by 213
Insulin action at a molecular level – 100 years of progress
White, M. F., & Kahn, C. R. (2021) · Molecular Metabolism · doi:10.1016/j.molmet.2021.101304 · Cited by 212
“This in turn can trigger activation of PKC isoforms that promote insulin resistance [199,200].”
BackgroundNonalcoholic fatty liver disease: Evolving paradigms
Lonardo, A., Nascimbeni, F., Maurantonio, M., Marrazzo, A., Rinaldi, L., & Adinolfi, L. E. (2017) · World Journal of Gastroenterology · doi:10.3748/wjg.v23.i36.6571 · Cited by 197
Zhou, B., Liu, C., Xu, L., Yuan, Y., Zhao, J., Zhao, W., Chen, Y., Qiu, J., Meng, M., Zheng, Y., et al. (2021) · Hepatology · doi:10.1002/hep.31220 · Cited by 194
“HS is usually associated with insulin resistance and hyperglycemia,(26,27) causing adverse systemic effects.”
BackgroundVarra, F.-N., Varras, M., Varra, V.-K., & Theodosis‑Nobelos, P. (2024) · Molecular Medicine Reports · doi:10.3892/mmr.2024.13219 · Cited by 190
“…retaining normal glucose levels (222). regarding the effect of insulin on lipid metabolism, insulin inhibits lipolysis (antilipolytic action), increases hepatic lipid synthesis for subse‑ quent TGs storage in aT (223) and stimulates glucose uptake into the skeletal muscles, heart and AT (220).”
BackgroundInterorgan Metabolic Crosstalk in Human Insulin Resistance
Gancheva, S., Jelenik, T., Álvarez-Hernández, E., & Roden, M. (2018) · Physiological Reviews · doi:10.1152/physrev.00015.2017 · Cited by 192
Hepatic lipid droplet homeostasis and fatty liver disease
Seebacher, F., Zeigerer, A., Kory, N., & Krahmer, N. (2020) · Seminars in Cell & Developmental Biology · doi:10.1016/j.semcdb.2020.04.011 · Cited by 190
Haghighatpanah, M., Nejad, A. S. M., Haghighatpanah, M., Thunga, G., & Mallayasamy, S. (2018) · Osong Public Health and Research Perspectives · doi:10.24171/j.phrp.2018.9.4.05 · Cited by 186
“Insulin resistance and glucose intolerance results in hyperglycemia and alterations in lipid and protein metabolism [3].”
BackgroundJiang, S., Young, J., Wang, K., Qian, Y., & Cai, L. (2020) · Molecular Medicine Reports · doi:10.3892/mmr.2020.11175 · Cited by 186
“G6P, glucose 6-phosphate; GP, glycogen phosphorylase; GS, glycogen synthase; GK, glucokinase; G6Pase, glucose-6-phosphotase. by reduced hepatic glycogen synthesis due to the diminished insulin signaling induced by lipid accumulation in various organs (50).”
Muscle and adipose tissue insulin resistance: malady without mechanism?
Fazakerley, D. J., Krycer, J. R., Kearney, A. L., Hocking, S. L., & James, D. E. (2019) · Journal of Lipid Research · doi:10.1194/jlr.r087510 · Cited by 185
“Impaired insulin action in other tissues, most notably the liver (4, 5), brain (6, 7)”
BackgroundHuman hepatic 3D spheroids as a model for steatosis and insulin resistance
Kozyra, M., Johansson, I., Nordling, Å., Ullah, S., Lauschke, V. M., & Ingelman-Sundberg, M. (2018) · Scientific Reports · doi:10.1038/s41598-018-32722-6 · Cited by 173
Adipose tissue mTORC2 regulates ChREBP-driven de novo lipogenesis and hepatic glucose metabolism
Tang, Y., Wallace, M., Sanchez-Gurmaches, J., Hsiao, W.-Y., Li, H., Lee, P. L., Vernia, S., Metallo, C. M., & Guertin, D. A. (2016) · Nature Communications · doi:10.1038/ncomms11365 · Cited by 171
“(1) In adipocytes, mTORC2 phosphorylates AKT in the hydrophobic motif (S473 in AKT1; S474 in AKT2) while PDK1 phosphorylates AKT in the kinase domain (T308 in AKT1; T309 in AKT2), which promotes maximal AKT activity.”
A Membrane-Bound Diacylglycerol Species Induces PKCϵ-Mediated Hepatic Insulin Resistance
Lyu, K., Zhang, Y., Zhang, D., Kahn, M., ter Horst, K. W., Rodrigues, M. R. S., Gaspar, R. C., Hirabara, S. M., Luukkonen, P. K., Lee, S., et al. (2020) · Cell Metabolism · doi:10.1016/j.cmet.2020.08.001 · Cited by 170
“Instead, among all the lipid species associated with NAFLD, DAGs and ceramides are the leading candidates thought to be involved (Chavez and Summers, 2012; Kusminski and Scherer, 2019; Petersen and Shulman, 2017; Samuel and Shulman, 2016).”
BackgroundSelf-citationKubota, T., Kubota, N., & Kadowaki, T. (2017) · Cell Metabolism · doi:10.1016/j.cmet.2017.03.004 · Cited by 169
“In fact, in mice that lack IR in the brain, hepatic TG secretion was reduced (Scherer et al., 2016).”
BackgroundSingh, A., Shadangi, S., Gupta, P. K., & Rana, S. (2025) · Comprehensive Physiology · doi:10.1002/cph4.70003 · Cited by 163
The role of skeletal muscle Akt in the regulation of muscle mass and glucose homeostasis
Jaiswal, N., Gavin, M. G., Quinn, W. J., Luongo, T. S., Gelfer, R. G., Baur, J. A., & Titchenell, P. M. (2019) · Molecular Metabolism · doi:10.1016/j.molmet.2019.08.001 · Cited by 167
Cheng, Y., Fang, Z., Zhang, X., Wen, Y., Lu, J., He, S., & Xu, B. (2023) · Cardiovascular Diabetology · doi:10.1186/s12933-023-01794-8 · Cited by 165
“Finally, higher TG levels may induce raised plasma free fatty acid (FFA) levels, a major cause of obesity-associated IR and cardiovascular disease [21, 45].”
Backgroundter Horst, K. W., Gilijamse, P. W., Versteeg, R. I., Ackermans, M. T., Nederveen, A. J., la Fleur, S. E., Romijn, J. A., Nieuwdorp, M., Zhang, D., Samuel, V. T., et al. (2017) · Cell Reports · doi:10.1016/j.celrep.2017.05.035 · Cited by 162
“Recent animal studies showed that themajor underlyingmechanism for hepatic insulin resistance involves hepatic DAG-induced PKCε activation (Kumashiro et al., 2011; Petersen et al., 2016; Samuel and Shulman, 2016), but efforts to translate this paradigm to humans have been limited.”
InfluentialSelf-citationLean, but not healthy: the ‘metabolically obese, normal-weight’ phenotype
Ding, C., Chan, Z., & Magkos, F. (2016) · Current Opinion in Clinical Nutrition & Metabolic Care · doi:10.1097/mco.0000000000000317 · Cited by 159
Kumar, V., Xin, X., Ma, J., Tan, C., Osna, N., & Mahato, R. I. (2021) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2021.113888 · Cited by 160
Lee, J., Kim, B., Kim, W., Ahn, C., Choi, H. Y., Kim, J. G., Kim, J., Shin, H., Kang, J. G., & Moon, S. (2021) · Scientific Reports · doi:10.1038/s41598-021-82053-2 · Cited by 166
Mechanisms of Insulin Resistance in Primary and Secondary Nonalcoholic Fatty Liver
Jelenik, T., Kaul, K., Séquaris, G., Flögel, U., Phielix, E., Kotzka, J., Knebel, B., Fahlbusch, P., Hörbelt, T., Lehr, S., et al. (2017) · Diabetes · doi:10.2337/db16-1147 · Cited by 154
“Elevated hepatic TG deposition results mainly from intrahepatic de novo lipogenesis (DNL) (primary NAFL [PRIM]) or from uptake and esterification of fatty acids from sources such as adipose tissue lipolysis and dietary intake (secondary NAFL [SEC]) (3,4).”
BackgroundSelf-citationGoldberg, I. J., Reue, K., Abumrad, N. A., Bickel, P. E., Cohen, S., Fisher, E. A. A., Galis, Z. S., Granneman, J. G., Lewandowski, E. D., Murphy, R. C., et al. (2018) · Circulation · doi:10.1161/circulationaha.118.033704 · Cited by 161
Self-citationGalicia-García, U., Jebari‐Benslaiman, S., Larrea, A., Uribe, K. B., Siddiqi, H. F., Ostolaza, H., Benito‐Vicente, A., & Martín, C. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21134725 · Cited by 181
“This condition is characterized by a pathophysiologic failure to proper respond to normal circulatory levels of insulin in insulin-sensitive cells, such as adipocytes, skeletal muscle cells and hepatocytes [90].”
BackgroundMechanisms by which adiponectin reverses high fat diet-induced insulin resistance in mice
Li, X., Zhang, D., Vatner, D. F., Goedeke, L., Hirabara, S. M., Zhang, Y., Perry, R. J., & Shulman, G. I. (2020) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1922169117 · Cited by 158
“resistance, WAT lipolysis is resistant to suppression by insulin, leading to increased nonesterified fatty acid (NEFA) delivery to the liver and muscle, which may further promote increased liver and muscle ectopic lipid content (4, 5, 32, 33).”
BackgroundSelf-citationBednarz, K., Kowalczyk, K., Cwynar, M., Czapla, D., Czarkowski, W., Kmita, D., Nowak, A., & Madej, P. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23084334 · Cited by 148
“The excess nutrients cause hypertrophy or hyperplasia of adipocyte and induces IR, hyperinsulinemia [11], higher serum free fatty acids, lipogenesis, and increased fat storage in the liver, pancreas, and skeletal muscles [13].”
BackgroundXu, H., Du, X., Xu, J., Zhang, Y., Tian, Y., Liu, G., Wang, X., Ma, M., Du, W., Liu, Y., et al. (2020) · PLoS Biology · doi:10.1371/journal.pbio.3000603 · Cited by 154
“Insulin resistance, also known as low insulin sensitivity, is a common feature of many human diseases [4,5].”
BackgroundSaponins from Sea Cucumber and Their Biological Activities
Zhao, Y., Xue, C., Zhang, T., & Wang, Y.-M. (2018) · Journal of Agricultural and Food Chemistry · doi:10.1021/acs.jafc.8b01770 · Cited by 155
Yang, K., Hung, H., Lu, C., Chang, H., Lee, L., & Huang, K. (2016) · Scientific Reports · doi:10.1038/srep27034 · Cited by 152
“Increase in hepatic fat in insulin-resistant subjects arises because of dietary fat and adipocyte lipolysis without invoking insulin-driven de novo hepatic lipogenesis 23,62 .”
InfluentialMoraes‐Vieira, P. M., Saghatelian, A., & Kahn, B. B. (2016) · Diabetes · doi:10.2337/db16-0221 · Cited by 157
“The major pathogenic factors for T2D are insulin resistance in peripheral tissues and dysregulated insulin secretion (6).”
Portincasa, P., Khalil, M., Mahdi, L., Perniola, V., Idone, V., Graziani, A., Baffy, G., & Ciaula, A. D. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25115640 · Cited by 181
“Sci. 2024 , 25 , 5640 gluconeogenesis [79] , resulting in increased production of glucose [124] and increased DNL.”
BackgroundHonka, M.-J., Latva-Rasku, A., Bucci, M., Virtanen, K. A., Hannukainen, J. C., Kalliokoski, K. K., & Nuutila, P. (2018) · European Journal of Endocrinology · doi:10.1530/eje-17-0882 · Cited by 140
Püschel, G. P., Klauder, J., & Henkel, J. (2022) · Journal of Clinical Medicine · doi:10.3390/jcm11154358 · Cited by 169
Absence of ANGPTL4 in adipose tissue improves glucose tolerance and attenuates atherogenesis
Aryal, B., Singh, A. K., Zhang, X., Varela, L., Rotllan, N., Goedeke, L., Chaube, B., Camporez, J.-P., Vatner, D. F., Horvath, T. L., et al. (2018) · JCI Insight · doi:10.1172/jci.insight.97918 · Cited by 127
“leads to accumulation of diacylglycerol (DAG), which in turn promotes IR by enhancing the activation of protein kinase Cε (PKCε) and PKCθ in liver and muscle, respectively, leading to impaired insulin signaling (6, 7).”
Self-citationIntestinal Fructose and Glucose Metabolism in Health and Disease
Merino, B., Fernández-Díaz, C. M., Cózar‐Castellano, I., & Perdomo, G. (2019) · Nutrients · doi:10.3390/nu12010094 · Cited by 164
Why Do Men Accumulate Abdominal Visceral Fat?
Nauli, A. M., & Matin, S. (2019) · Frontiers in Physiology · doi:10.3389/fphys.2019.01486 · Cited by 168
“A recent study shows that testosterone is capable of suppressing the LPL activity and fat storage in the femoral region (Santosa et al., 2017).”
BackgroundChen, J., Wu, K., Lin, Y., Huang, M.-Y., & Xie, S.-H. (2023) · Cardiovascular Diabetology · doi:10.1186/s12933-023-02054-5 · Cited by 139
“Furthermore, IR can cause a metabolic imbalance in individuals with diabetes [22], leading to hyperglycemia, inflammation, oxidative stress, and disruptions in lipid metabolism [23, 24].”
BackgroundJiang, Z., Zhao, M., Coassolo, L., Jung, Y., Aikio, M., Sahai, T., Dou, F. Y., Roche, A. M., Carcamo‐Orive, I., Knowles, J. W., et al. (2021) · Cell Metabolism · doi:10.1016/j.cmet.2021.07.010 · Cited by 143
“Glucose homeostasis balances glucose uptake, mainly by skeletal muscle, heart, and adipose tissue, and glucose production, predominantly by the liver, kidney, 1836 Cell Metabolism 33, 1836–1852, September 7, 2021 ª 2021 Els and gut (Petersen et al., 2017; Samuel and Shulman, 2016).”
BackgroundSelf-citationZhou, Y., Xu, N., Zhang, X., Zhu, Y., Liu, S., & Chang, Y. (2021) · Journal of Agricultural and Food Chemistry · doi:10.1021/acs.jafc.1c01109 · Cited by 137
Insulin resistance and bone: a biological partnership
Conte, C., Epstein, S., & Napoli, N. (2018) · Acta Diabetologica · doi:10.1007/s00592-018-1101-7 · Cited by 136
“The pathophysiology of insulin resistance is complex, a main mechanism being ectopic lipid accumulation in liver and skeletal muscle, along with adipocyte dysfunction [19].”
BackgroundWang, T., Li, M., Zeng, T., Hu, R., Xu, Y., Xu, M., Zhao, Z., Chen, Y., Wang, S., Lin, H., et al. (2022) · Diabetes Care · doi:10.2337/dc22-0202 · Cited by 137
Herrera‐Balandrano, D. D., Chai, Z., Hutabarat, R. P., Trust Beta, Feng, J., Ma, K., Li, D., & Huang, W. (2021) · Redox Biology · doi:10.1016/j.redox.2021.102100 · Cited by 137
Xue, C., Chen, K., Gao, Z., Bao, T., Dong, L., Zhao, L., Tong, X., & Li, X. (2023) · Cell Communication and Signaling · doi:10.1186/s12964-022-01016-w · Cited by 161
“…hallmarks closely coordinated with each other to provoke endothelial dysfunction in DVCs: one is hyperglycemia induced by insufficient insulin secretion or insulin resistance (IR), and another is chronic, low-grade inflammation induced by proinflammatory immune cells and released cytokine [16].”
BackgroundEndothelial Cell Receptors in Tissue Lipid Uptake and Metabolism
Abumrad, N. A., Cabodevilla, A. G., Samovski, D., Pietka, T., Basu, D., & Goldberg, I. J. (2021) · Circulation Research · doi:10.1161/circresaha.120.318003 · Cited by 131
Mu, W., Cheng, X., Liu, Y., Lv, Q., Gao-lin, L., Zhang, J.-G., & Li, X. (2019) · Frontiers in Pharmacology · doi:10.3389/fphar.2018.01566 · Cited by 146
Inflammation‐mediated metabolic regulation in adipose tissue
Xu, S., Lu, F., Gao, J., & Yuan, Y. (2024) · Obesity Reviews · doi:10.1111/obr.13724 · Cited by 148
“16,121”
Lonardo, A., Ballestri, S., Guaraldi, G., Nascimbeni, F., Romagnoli, D., Zona, S., & Targher, G. (2016) · World Journal of Gastroenterology · doi:10.3748/wjg.v22.i44.9674 · Cited by 135
ter Horst, K. W., Schene, M. R., Holman, R., Romijn, J. A., & Serlie, M. J. M. (2016) · American Journal of Clinical Nutrition · doi:10.3945/ajcn.116.137786 · Cited by 132
Tricò, D., Natali, A., Arslanian, S. A., Mari, A., & Ferrannini, E. (2018) · JCI Insight · doi:10.1172/jci.insight.124912 · Cited by 121
“It also adversely affects body composition by increasing intracellular fat storage (24, 28).”
Background
Metadata
- Authors
- Samuel, V. T., & Shulman, G. I.
- Affiliations
- Veterans Health Administration (US)
- Howard Hughes Medical Institute (US)
- Venue
- Journal of Clinical Investigation
- Published
- 2016-01-04
- Volume
- 126
- Issue
- 1
- Pages
- 12-22
- ISSN
- 0021-9738 (ISSN-L)
- 1558-8238
- PMC
- PMC4701542
- OpenAlex
- W2230222215
- Cited by
- 1,484
- References
- 131
- Citations by year
- 2026: 192 · 2025: 162 · 2024: 152 · 2023: 150 · 2022: 150 · 2021: 143 · 2020: 134 · 2019: 136 · 2018: 114 · 2017: 99 · 2016: 51
- FWCI
- 18.06
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- Journal of Clinical Investigation (publishedVersion)
- Europe PMC (PubMed Central) (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Funders
- U.S. Department of Veterans Affairs (I01 BX000901)
- National Institute of Diabetes and Digestive and Kidney Diseases (DK-49230, R01DK049230, DK40936, DK 45735, R01DK040936, U24DK059635, R24DK085638, DK059635, DK-085638, P30DK045735)
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Adipokines, Inflammation, and Metabolic Diseases
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Metabolism, Diabetes, and Cancer
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes, Cardiovascular Risks, and Lipoproteins
- Keywords
- insulin resistance, type 2 diabetes, ectopic fat deposition, hepatic insulin signaling, skeletal muscle glucose uptake, hepatic gluconeogenesis, hepatic de novo lipogenesis, adipose tissue lipolysis, hepatic triglyceride synthesis, fatty acid esterification, hyperlipidemia, hyperglycemia, pyruvate carboxylase, acetyl-CoA, substrate flux, inflammation, energy surplus
- MeSH terms
- Adipose Tissue, Animals, Glucose, Humans, Insulin Resistance, Liver, Triglycerides, Signal Transduction, Muscle, Skeletal, Lipid Metabolism
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.